Issue №2-90, 2019

Forming a long-term strategy for treating osteoporosis as the basis for effective rehabilitation of patients with pathological fractures: new scientific data and practical solutions

View article (Download PDF file)



Download XML file

1 Marchenkova L.A., 1 Makarova E.V., 2 Salamadina M.O.

1 «National Medical Research Center of Rehabilitation and Balneology», Moscow, Russia
2 «I.M. Sechenov First Moscow State Medical University (Sechenov University)», Moscow, Russia


ABSTRACT




References:

  1. Marchenkova L.A. Postmenopauzal’nyj osteoporoz kak mediko-social’naya i ehkonomicheskaya problema XXI V. Farmateka. 2015. № S4. S. 13-21
  2. M.R. McClung, J. San Martin, P.D. Miller, R. Civitelli, F. Bandeira, M. Omizo, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass Arch Intern Med, 165 (2005), pp. 1762-1768
  3. J. Jolette, B. Attalla, A. Varela, G.G. Long, N. Mellal, S. Trimm, et al. Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34) Regul Toxicol Pharmacol, 86 (2017), pp. 356-365
  4. Michael R.McClung. Romosozumab for the treatment of osteoporosis. Osteoporosis and Sarcopenia Volume 4, Issue 1, March 2018, Pages 11-15
  5. Abstract book of World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, 19-22 April 2018, Krakow, Poland // Osteoporosis International. V. 29 (suppl. 1), April 2018.
  6. Marchenkova L.A. Dokazatel’naya baza ehffektivnosti i bezopasnosti teriparatida pri osteoporoze. V sbornike: Sovremennye podhody k diagnostike i lecheniyu osteoporoza: ot nauki k klinicheskoj praktike. Sbornik materialov H obrazovatel’nogo kursa SHkoly osteoporoza dlya vrachej. Nauchno-Issledovatel’skij Klinicheskij Institut im. M. F. Vladimirskogo; GBUZ MO MONIKI im. M. F. Vladimirskogo. 2015.S. 25-26.
  7. Marchenkova L.A., Martynova E.YU., Dobricyna M.A., Badalov N.G., Konchugova T.V. Analiz ehffektivnosti i klinicheskih perspektivnemedikamen-toznyh metodov lecheniya i profilaktiki osteoporoza. V knige: Dostizheniya personalizirovannoj mediciny segodnya - rezul’tat prakticheskogo zdra-voohraneniya zavtra sbornik tezisov VII Vserossijskogo kongressa ehndokrinologov. FGBU “EHndokrinologicheskij nauchnyj centr” Minzdrava Rossii; Ministerstvo zdravoohraneniya Rossijskoj Federacii; Obshchestvennaya organizaciya “Rossijskaya associaciya ehndokrinologov”. 2016. S. 340.
  8. Marchenkova L.A. Obzor poslednih issledovanij po ehffektivnosti i bezopasnosti denosumaba pri osteoporoze. V sbornike: Sovremennye podhody k diagnostike i lecheniyu osteoporoza: ot nauki k klinicheskoj praktike. Sbornik materialov H obrazovatel’nogo kursa SHkoly osteoporoza dlya vrachej. Nauchno-Issledovatel’skij Klinicheskij Institut im. M. F. Vladimirskogo; GBUZ MO MONIKI im. M. F. Vladimirskogo. 2015. S. 23-24.
  9. Marchenkova L.A., Makarova E.V. Novye vozmozhnosti i perspektivy peroral’noj terapii osteoporoza. Lechashchij vrach. 2017. № 12. S. 35.
  10. Marchenkova L.A. Vozmozhnosti terapii osteoporoza bisfosfonatom alendronatom v praktike vracha pervichnogo zvena. Lechashchij vrach. 2017. № 3. S. 12.



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©

Эта статья открытого доступа по лицензии CC BY 4.0. Издательство: ФГБУ «НМИЦ РК» Минздрава России.
This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.